154 related articles for article (PubMed ID: 9021179)
1. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells.
Pascual A; García I; Ballesta S; Perea EJ
Antimicrob Agents Chemother; 1997 Feb; 41(2):274-7. PubMed ID: 9021179
[TBL] [Abstract][Full Text] [Related]
2. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.
Pascual A; García I; Ballesta S; Perea EJ
Antimicrob Agents Chemother; 1999 Jan; 43(1):12-5. PubMed ID: 9869557
[TBL] [Abstract][Full Text] [Related]
3. Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells.
García I; Pascual A; Guzman MC; Perea EJ
Antimicrob Agents Chemother; 1992 May; 36(5):1053-6. PubMed ID: 1324636
[TBL] [Abstract][Full Text] [Related]
4. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells.
García I; Pascual A; Ballesta S; Perea EJ
Int J Antimicrob Agents; 2000 Aug; 15(3):201-5. PubMed ID: 10926442
[TBL] [Abstract][Full Text] [Related]
5. Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes.
García I; Pascual A; Perea EJ
Antimicrob Agents Chemother; 1994 Oct; 38(10):2426-9. PubMed ID: 7840582
[TBL] [Abstract][Full Text] [Related]
6. Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytes.
García I; Pascual A; Ballesta S; Joyanes P; Perea EJ
Antimicrob Agents Chemother; 2000 Nov; 44(11):3193-5. PubMed ID: 11036051
[TBL] [Abstract][Full Text] [Related]
7. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.
Firsov AA; Vostrov SN; Kononenko OV; Zinner SH; Portnoy YA
Antimicrob Agents Chemother; 1999 Mar; 43(3):498-502. PubMed ID: 10049257
[TBL] [Abstract][Full Text] [Related]
9. Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells.
Pascual A; Garcia I; Perea EJ
Diagn Microbiol Infect Dis; 1992 Jul; 15(5):393-8. PubMed ID: 1322808
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
Bonilla HF; Zarins LT; Bradley SF; Kauffman CA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):17-21. PubMed ID: 8950524
[TBL] [Abstract][Full Text] [Related]
11. Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils.
García I; Pascual A; Salvador J; Conejo MC; Perea EJ
J Antimicrob Chemother; 1996 Nov; 38(5):859-63. PubMed ID: 8961056
[TBL] [Abstract][Full Text] [Related]
12. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
Perea EJ; García I; Pascual A
Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
Felmingham D; Robbins MJ; Ingley K; Mathias I; Bhogal H; Leakey A; Ridgway GL; Grüneberg RN
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():43-9. PubMed ID: 9222069
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa in vitro corneal isolate sensitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative study.
Song A; McCulley TJ; Lam BL; Feuer WJ; Miller D; Alfonso EC
Am J Ophthalmol; 2001 Jun; 131(6):795-6. PubMed ID: 11384579
[TBL] [Abstract][Full Text] [Related]
15. Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Prenna M; Montanari MP; Mingoia M; Biavasco F; Ripa S; Varaldo PE
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):816-9. PubMed ID: 9923533
[No Abstract] [Full Text] [Related]
16. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
Isenberg HD; Alperstein P; France K
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
Bauernfeind A
J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
[TBL] [Abstract][Full Text] [Related]
19. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
[TBL] [Abstract][Full Text] [Related]
20. Selection of fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus with ciprofloxacin and trovafloxacin.
Evans ME; Titlow WB
Antimicrob Agents Chemother; 1998 Mar; 42(3):727. PubMed ID: 9517965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
